Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

Details

Database :

OAIster

Notes :

application/pdf, Blood Cancer Journal vol. 10 no. 5, English

Publication Type :

Electronic Resource

Accession number :

edsoai.on1157012435

Document Type :

Electronic Resource

Full Text :

https://doi.org/10.1038.s41408-020-0326-1